NCT00297583View on ClinicalTrials.gov

Insulin Glulisine in Type 1 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

April 30, 2004

Primary Completion Date

May 31, 2004

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG

Insulin Glulisine

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY